Table III.
rs1456315 | rs7007694 | rs7841060 | rs13252298 | Controls (frequency) | PCa (frequency) | OR (95% CI) | P-value |
---|---|---|---|---|---|---|---|
A | T | T | G | 0.3828 | 0.3367 | 1.00 | – |
A | T | T | A | 0.227 | 0.1987 | 1.29 (0.60–2.79) | 0.52 |
G | T | G | A | 0.146 | 0.2293 | 5.09 (2.45–10.59) | <0.0001 |
G | T | G | G | 0.0303 | 0.1473 | 18.85 (4.93–72.00) | <0.0001 |
A | C | T | G | 0.0492 | 0.0293 | 0.82 (0.16–4.17) | 0.81 |
A | C | T | A | 0.0496 | 0.011 | 0.85 (0.21–3.37) | 0.81 |
G | T | T | A | 0.053 | 0.0031 | 0.21 (0.02–1.74) | 0.15 |
A | T | G | A | 0.047 | 0.0062 | 0.61 (0.15–2.52) | 0.49 |
PRNCR1, prostate cancer-associated non-coding RNA 1; PCa, prostate cancer; OR, odds ratio; CI, confidence interval.